Your browser doesn't support javascript.
loading
Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma.
Geva, Michal; Gershoni-Emek, Noga; Naia, Luana; Ly, Philip; Mota, Sandra; Rego, Ana Cristina; Hayden, Michael R; Levin, Leonard A.
Affiliation
  • Geva M; Prilenia Therapeutics, Herzliya, Israel.
  • Gershoni-Emek N; Prilenia Therapeutics, Herzliya, Israel.
  • Naia L; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
  • Ly P; Department of Neurobiology, Care Science and Society, Karolinska Institutet, Stockholm, Sweden.
  • Mota S; The Centre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada.
  • Rego AC; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
  • Hayden MR; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
  • Levin LA; FMUC-Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Sci Rep ; 11(1): 21975, 2021 11 09.
Article in En | MEDLINE | ID: mdl-34753986
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Retinal Ganglion Cells / Glaucoma / Receptors, sigma / Neuroprotective Agents Limits: Animals Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: Israel Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Retinal Ganglion Cells / Glaucoma / Receptors, sigma / Neuroprotective Agents Limits: Animals Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: Israel Country of publication: United kingdom